Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 27, 2026 $200.00 +0.65% $197.38 X 98.67% 1
Apr 27, 2026 $198.71 +0.00% $197.38 V 99.33% 4
Apr 15, 2026 $212.61 +1.09% $208.43 X 97.99% 0
Apr 15, 2026 $208.89 -0.68% $208.43 V 99.78% 6
Apr 15, 2026 Bullish $208.43 V 0
Jan 20, 2026 $216.52 +1.01% $214.04 X 98.84% 1
Jan 20, 2026 $215.71 +0.63% $214.04 X 99.22% 2
Jan 20, 2026 Bullish $214.04 X 0
Sep 24, 2025 $221.19 -0.64% $219.99 V 99.45% 4
Sep 24, 2025 $221.72 -0.40% $219.99 V 99.21% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE